Source link : https://www.newshealth.biz/health-news/fda-approves-topical-tapinarof-for-atopic-dermatitis/
The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in adults and pediatric patients 2 years of age and older. An aryl hydrocarbon receptor agonist, tapinarof cream, 1% was first approved in May 2022 for the topical treatment of plaque psoriasis in adults. According to […]
Author : News Health
Publish date : 2024-12-16 19:34:51
Copyright for syndicated content belongs to the linked Source.